Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2005-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In rural regions of the U.S., reduced availability of primary care providers and specialty services, including diabetes education, present additional barriers to effective diabetes care. Use of a nurse practitioner led interdisciplinary team to intensively manage urban and rural diabetic patients, utilizing telehealth technology to provide care to rural areas, will help begin to address these barriers
The long term goal of the project is to develop a practical and sustainable system of intensive diabetes management that will be effective in helping diabetic patients achieve and maintain goals within established treatment guidelines regardless of geographic location.
Specific aims are:
1. To determine in both urban and rural areas if a nurse practitioner led team approach to intensive diabetes management and education improves disease-specific outcomes and patient education compared to traditional care (current diabetes management of urban patients).
2. To determine if telehealth is an effective and accepted mechanism for delivery of a nurse practitioner led team approach to intensive diabetes management and education in rural areas.
3. To determine if a nurse practitioner led intensive disease management team can identify patient risk factors (psychological, financial, and work-related factors) that may be barriers to patient adherence, earlier in the management of urban diabetic patients compared to traditional care.
4. To compare volume and type of service utilization of a nurse practitioner led team approach to diabetes management and education to that of traditional care in both urban and rural areas. Disease-specific outcomes will include physiologic variables (HbA1c, blood pressure, lipid levels), measurement and documentation of preventive services (dilated eye exam, monofilament exam, microabumin testing) and patient's knowledge of disease tested by questionnaire.
Results should show improved outcomes and patient knowledge in urban and rural patients receiving intensive disease management compared to traditional care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Clinical Inertia in Diabetes Care
NCT00272402
Proactive Diabetes Case Management
NCT00013208
Disease Management and Educational Intervention Outcomes in High-Risk Diabetics
NCT00012662
Breaking Down Barriers to Diabetes Self-Care
NCT00142922
Diabetes Outcomes and Nurse Case Manager Study
NCT01659294
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nurse Practitioner led multidisciplinary team approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All persons with diabetes who do not meet ADA goals for glycemic, blood pressure or lipid control.This includes new or previously diagnosed patients.
* Men and women 21 years of age or older.
* Speaks and reads English
* Willing to participate (informed consent)
Exclusion Criteria
* Diagnosis of dementia or mental retardation.
* Resident of personal care home, assisted living, or long term care facility.
* Significant drug/alcohol abuse in the past 18 months.
* Active malignant process including patients on chemotherapy.
* Steroid induced diabetes or patient on chronic or intermittent steroid therapy (use for more than 2 months out of a year)
* Acute or chronic inflammatory or infectious disease process (chronic osteomyelitis, HIV, tuberculosis, bacterial endocarditis)
* End stage renal or liver disease.
* Pregnancy.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia J Coon, MD
Role: PRINCIPAL_INVESTIGATOR
Deaconess Billings Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deaconess Billings Clinic Center on Aging
Billings, Montana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
65787 (completed)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.